Skip to main content
Equibles

LOS ANGELES CAPITAL MANAGEMENT LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1177206 LOS ANGELES, CA
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$606,266
-$229,552 QoQ
Shares Held
531,813
-11.6% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 170 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority Sole 4% Shared 0% None 96%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $64,712,202 across 30 Drug Manufacturers - Specialty & Generic names. AKBA ranks #8 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 203,548 $34,305,979
2 VTRS
Viatris Inc
 751,406 $11,932,327
3 LQDA
Liquidia Corp
 54,603 $4,353,497
4 KNSA
Kiniksa Pharmaceuticals International, plc
 50,786 $3,247,764
5 COLL
Collegium Pharmaceutical, Inc
 89,443 $3,237,836
6 PAHC
Phibro Animal Health Corp
 67,083 $2,106,406
7 IRWD
Ironwood Pharmaceuticals Inc
 342,293 $1,441,053
8 AKBA
Akebia Therapeutics, Inc.
This page 		531,813 $606,266

All Filings in AKBA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $606,266 531,813
2026-03-31 $835,818 601,308
2025-12-31 $47,667 29,607
2025-09-30 $80,827 29,607
2025-06-30 $97,344 26,743
2025-03-31 $51,212 26,673
2020-09-30 $66,640 26,550
2020-06-30 $193,379 14,240